Hepatitis C screening and management practices: a survey of drug treatment and syringe exchange programs in New York City

. 2002 Aug;92(8):1254-6.

doi: 10.2105/ajph.92.8.1254.

Affiliations

Chi-Chi N Udeagu Pratt et al. Am J Public Health. 2002 Aug.

. 2002 Aug;92(8):1254-6.

doi: 10.2105/ajph.92.8.1254.

¹ Communicable Disease Program, New York City Department of Health, New York, NY 10013, USA.

No abstract available

Cited by

Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users.
Edlin BR, Kresina TF, Raymond DB, Carden MR, Gourevitch MN, Rich JD, Cheever LW, Cargill VA. Edlin BR, et al. Clin Infect Dis. 2005 Apr 15;40 Suppl 5(Suppl 5):S276-85. doi: 10.1086/427441. Clin Infect Dis. 2005. PMID: 15768335 Free PMC article. Review.
Hepatitis C virus infection in San Francisco's HIV-infected urban poor.
Hall CS, Charlebois ED, Hahn JA, Moss AR, Bangsberg DR. Hall CS, et al. J Gen Intern Med. 2004 Apr;19(4):357-65. doi: 10.1111/j.1525-1497.2004.30613.x. J Gen Intern Med. 2004. PMID: 15061745 Free PMC article.
Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs.
Platt L, Minozzi S, Reed J, Vickerman P, Hagan H, French C, Jordan A, Degenhardt L, Hope V, Hutchinson S, Maher L, Palmateer N, Taylor A, Bruneau J, Hickman M. Platt L, et al. Cochrane Database Syst Rev. 2017 Sep 18;9(9):CD012021. doi: 10.1002/14651858.CD012021.pub2. Cochrane Database Syst Rev. 2017. PMID: 28922449 Free PMC article.

1. Centers for Disease Control and Prevention. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR Morb Mortal Wkly Rep. 1998;47(RR-19):1–34. - PubMed
1. Alter MJ, Mast EE, Moyer LA, Margolis HS. Hepatitis C. Infect Dis Clin North Am. 1998;12:13–26. - PubMed
1. Garfein RS, Vlahov D, Galai N, Doherty MC, Nelson KE. Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. Am J Public Health. 1996;86:655–661. - PMC - PubMed
1. Alter MJ, Moyer LA. The importance of preventing hepatitis C virus infection among injection drug users in the United States. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18(suppl 1):6–9. - PubMed
1. Moyer LA, Mast EE, Alter MJ. Hepatitis C, II: prevention counseling and medical evaluation. Am Fam Physician. 1999;59:349–354. - PubMed